Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Candesartan cilexetil 4 mg, 8 mg, 16 mg Tablet Astra Pharmaceutical Production AB., Sodertalje, Sweden Atacand Ammonium carbonate 3.07 % w/w, camphor 0.04 % w/w, dextromethorphan hydrobromide 0.25 % w/w, menthol 0.43 % w/w Solution, oral W K Buckley Limited, Mississauga, Ontario, Canada Buckley's DM Choline theophyllinate 1.5 % w/v, guaiphenesin 0.75 % w/v Syrup Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Cough Expectorant Miconazole 2 % w/w Solution, topical Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia Fungo Solution Naratriptan hydrochloride 2.78 mg equivalent to 2.5 mg naratriptan Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Naramig Light liquid paraffin 70 % w/w Gel, topical Stiefel Laboratories (Ireland) Limited, Sligo, Eire and Stiefel Laboratories PTE Limited, Jurong, Singapore Oilatum Shower Gel Paracetamol 500 mg Tablet A H Cox & Co Limited, Whiddon Valley, Barnstaple, North Devon, United Kingdom Paracetamol Isoniazid 50 mg, pyrazinamide 300 mg, rifampicin 120 mg Tablet Gruppo Lepetit SpA., Anagni (Frosinone), Italy Rifater Iobitridol 548.4 mg/mL equivalent to 250 mg/mL iodine Injection, solution Laboratoires Guerbet, Aulnay-sous-Bois, France Xenetix 250 Iobitridol 658.1 mg/mL equivalent to 330 mg/mL iodine Injection, solution Laboratoires Guerbet, Aulnay-sous-Bois, France Xenetix 300 Iobitridol 767.8 mg/mL equivalent to 350 mg/mL iodine Injection, solution Laboratoires Guerbet, Aulnay-sous-Bois, France Xenetix 350 Dated this 11th day of May 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.